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Australian teaching hospital
Abstract
Introduction and Aims: Alcohol‐related morbidity is estimated to range from 10-38% of the presentations to
hospital emergency departments. This study aims to investigate the actual management process for
alcohol‐related presentations in a teaching hospital in Australia.
Design and Methods: Retrospective audit was conducted on the electronic medical records of 210
presentations with a primary or secondary diagnosis of 'alcohol use disorder' at discharge between November
2016 and February 2017. Six key management steps were investigated: identification of alcohol use disorder,
documentation, thiamine, alcohol withdrawal assessment, benzodiazepine for alcohol withdrawal and referral
to the drug and alcohol consultation liaison service.
Results: Of all the 210 presentations, 77.1% (162) were identified with alcohol use disorder in the initial
assessments; 64.3% (135) were documented with alcohol use history, 49.5% (104) were prescribed with
thiamine, 48.1% (101) were assessed with the alcohol withdrawal scale, 41% (86) were prescribed with
benzodiazepine for alcohol withdrawal and only 38.6% (81) were referred to the drug and alcohol
consultation liaison service. Only 8.6% (18) of the initial presentations were directly related to alcohol. These
presentations had a higher completion rate in each of the six steps than those (91.4%, 192) not directly related
to alcohol. Only 6.2% (13) were formally screened for alcohol use.
Discussion and Conclusions: The findings suggest a need to improve the alcohol management practice in
the hospital. Routine use of an alcohol screening tool can enable early identification of the alcohol use
disorder and to improve the management of this problem in the hospital.
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Title: Investigating the management of alcohol-related presentations in an Australian 1 
teaching hospital 2 
 3 
Introduction and Aims 4 
Alcohol-related morbidity is estimated to range from 10% to 38% of the presentations to 5 
hospital emergency departments. This study aims to investigate the actual management 6 
process for alcohol-related presentations in a teaching hospital in Australia.  7 
Design and Methods 8 
Retrospective audit was conducted on the electronic medical records of 210 presentations 9 
with a primary or secondary diagnosis of “alcohol use disorder” at discharge between 10 
November 2016 and February 2017. Six key management steps were investigated: 11 
identification of alcohol use disorder, documentation, thiamine, alcohol withdrawal 12 
assessment, benzodiazepine for alcohol withdrawal and referral to the drug and alcohol 13 
consultation liaison service.  14 
Results 15 
Of all the 210 presentations, 77.1% (162) were identified with alcohol use disorder in the 16 
initial assessments, 64.3% (135) were documented with alcohol use history, 49.5% (104) 17 
were prescribed with thiamine, 48.1% (101) were assessed with the alcohol withdrawal scale, 18 
41% (86) were prescribed with benzodiazepine for alcohol withdrawal and only 38.6% (81) 19 
were referred to the drug and alcohol consultation liaison service. Only 8.6% (18) of the 20 
initial presentations were directly related to alcohol. These presentations had a higher 21 
completion rate in each of the six steps than those (91.4%, 192) not directly related to alcohol. 22 
Only 6.2% (13) were formally screened for alcohol use. 23 
Discussion and Conclusions 24 
The findings suggest a need to improve the alcohol management practice in the hospital. 25 
Routine use of an alcohol screening tool can enable early identification of the alcohol use 26 
disorder and to improve the management of this problem in the hospital. 27 
Keywords: alcohol use disorder, screen, management process, emergency departments, 28 
hospitals 29 
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1 Introduction 1 
Alcohol is one of the top five risk factors for disease and disability that caused 3.3 million 2 
deaths annually [1, 2]. In Australia, alcohol caused more than 5,500 deaths and 150,000 3 
hospitalisations in 2010 [3].  4 
With Emergency Department (ED) as the first “port of call” for many hospitalised patients, it 5 
is estimated that 10% to 38% of the ED presentations are alcohol-related [4-6]. An Australian 6 
study reported that 27% of ED patients used alcohol in the 24 hours prior to presentation [7]. 7 
Sadly this type of presentation is often unidentified [8]. As alcohol withdrawal and its 8 
complications such as seizures may occur 6 hours after the last drink [9], failure in 9 
identification of alcohol use disorder (AUD) can lead to unexpected acute alcohol 10 
withdrawal. This can further complicate emergency assessment and diagnosis, causing harm 11 
to patients [10].  12 
Early identification of AUD is essential for the medical staff to determine optimal clinical 13 
management of the patients [11]. An effective way is to use an alcohol screening tool to 14 
identify and assess whether alcohol is harming a person’s health or is likely to cause harm in 15 
the future. Although there are validated, formal alcohol screening tools available such as 16 
Alcohol Use Disorders Identification Test (AUDIT) [12], the Cut-down, Annoyed, Guilt, 17 
Eye-opener (CAGE) [13] and the Paddington Alcohol Test (PAT) [14], the use of these tools 18 
remains unsatisfactory in Australian hospitals [15]. This results in a significant proportion of 19 
patients with AUD unscreened or undiagnosed, exposing them to the risk of developing 20 
alcohol withdrawal symptoms or complications. A recent Australian study evaluated the 21 
effectiveness of a routine screening and triage tool for alcohol withdrawal syndrome [16]. 22 
The study specifically measured the completion rate of identification of alcohol withdrawal 23 
syndrome, documentation of alcohol use and appropriate withdrawal management before and 24 
after the intervention. It found that after the use of the tool, there was a significant increase in 25 
the rate of documentation of alcohol use from 35.4% pre-intervention to 55.2% post-26 
intervention. The rate of appropriate management also increased significantly from 31.8% to 27 
80% [16].  28 
When AUD is suspected, assessment and documentation of alcohol use history should be 29 
conducted. This includes information such as duration, quantity, pattern of use, previous 30 
attempts to cut down alcohol intake or psychosocial impact [17, 18]. Research on 31 
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documentation of alcohol use is sparse and is not specific to patients with AUD. One study of 1 
documentation pattern of alcohol use in electronic medical records (eMR) in primary care 2 
found that although 56% of the eMR had quantitative documentation of alcohol use, only 3 
26% had qualitative descriptions of this use [19]. Another similar study in hospital records 4 
for cancer patients found that in 57% of the documentation of alcohol use history was poorly 5 
described as social, occasional or moderate drinkers [20]. Therefore, there is a need to assess 6 
the documentation of alcohol use history for patients with AUD. 7 
Due to prolonged heavy alcohol consumption, patients with AUD suffer from thiamine 8 
deficiency [21]. Therefore, once identified, these patients should be provided with thiamine 9 
to prevent Wernicke’s encephalopathy, an acute neurological syndrome caused by thiamine 10 
deficiency [21-23]. The earlier thiamine is started, the faster the patient will recover [24]. 11 
Route of thiamine administration can be oral or parenteral. A retrospective medical record 12 
audit study found that among 226 patients, 89% (201) were prescribed with oral thiamine 13 
[25]. However, for patients at risk of alcohol withdrawal, only 4.5 mg of thiamine can be 14 
absorbed orally from any dose over 30 mg [26]; therefore, parenteral thiamine is the standard 15 
of care [21, 27].  16 
To assess severity of alcohol withdrawal and to guide therapy appropriately, several validated 17 
scales can be used [9]. The Alcohol Withdrawal Scale (AWS) requires less reliance on 18 
patients’ response by assessing four physiological indicators (pulse, body temperature, 19 
sweating and tremor) and five mental or psychopathological symptoms (agitation, anxiety, 20 
tactile disturbances, disorientation and hallucination) common to alcohol withdrawal [28]. 21 
According to the Clinical Institute Withdrawal Assessment for Alcohol scale in its revised 22 
version (CIWA-Ar), the severity of alcohol withdrawal should be estimated by observation 23 
with patient participation [9]. In case of lacking patient cooperation, other tools can be used, 24 
such as the Richmond Agitation-Sedation Scale which is generally applicable to intensive 25 
care patients [9, 29].  26 
To prevent progression to a more severe withdrawal, benzodiazepine is recommended to be 27 
used early in the management of alcohol withdrawal [17]. Despite the fact that within the first 28 
two days of withdrawal, benzodiazepine reduces the incidence of seizures by up to 84% and 29 
prevent the development of delirium tremens [9], a previous study found that only 37% of 30 
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patients with AUD were prescribed with benzodiazepine for alcohol withdrawal management 1 
[30]. 2 
To provide effective advice on inpatient withdrawal management, assess patients’ readiness 3 
to change alcohol consumption behaviour and assist them to meet their goal, it is 4 
recommended that clinicians refer every patient with AUD to the hospital-based Drug and 5 
Alcohol Consultation Liaison (DA-CL) specialist service [17]. However, it is found that in 6 
practice, only 51% of the patients with AUD were referred to the specialist treatment services 7 
including Drug and Alcohol Service [30] and only 27% of ED staff provided these patients 8 
with formal referral to the outpatient alcohol service [31]. 9 
With the above prior knowledge, this research aims to understand and identify gaps in the 10 
actual management process of patients with AUD in a teaching hospital in Australia. 11 
Specifically, six key steps in the management of patients with AUD in hospitals were 12 
examined: identification of AUD, documentation of alcohol use history, thiamine use, alcohol 13 
withdrawal assessment, benzodiazepine for treatment of alcohol withdrawal and referral to 14 
the DA-CL service.  15 
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2 Methods 1 
2.1 Study design 2 
The study was conducted in a teaching hospital in New South Wales, Australia. To allow the 3 
inclusion of any alcohol-related presentations, the diagnosis-related group (DRG) “AUD” 4 
acquired on discharge was used to identify these presentations. This umbrella term includes 5 
both apparent alcohol induced symptoms e.g. intoxication, and complications e.g. alcoholic 6 
pancreatitis, of which initial disclosure are more difficult. Three hundred and sixty-seven 7 
consecutive patient presentations with a primary or secondary discharge diagnosis of AUD 8 
between 15 November 2016 and 15 February 2017 were identified retrospectively.  9 
Among these consecutive presentations, 210 (57.2%) presentations incurred by 199 patients 10 
were randomly selected. These included patients who were triaged and assessed in the ED, 11 
those who were directly admitted to the hospital wards and inter-hospital transfers. The 12 
randomization was performed in the IBM SPSS Statistics. As no paper file was used in the 13 
study hospital, all the patient information was extracted from the eMR for this audit research. 14 
Audit of one patient record requires 30-minute manual work by the advanced trainee who 15 
could only afford half a day per week for research. That totals up to 105 hours of work. Given 16 
this constraint, the sample size may seem small, however it accounts for 57.2% of the total 17 
population. 18 
An investigation of hospital re-presentation, re-admission and attendance to the community-19 
based Drug and Alcohol Service was also conducted 17 months after patient discharge. 20 
The project was approved by the hospital authority as meeting the requirements for quality 21 
assurance/audit and therefore it did not require consideration by the Human Research Ethics 22 
Committees. 23 
2.2 Development of the audit protocol for extraction of data variables from the 24 
medical records  25 
A collaborative, consensus-based, multi-disciplinary approach was used to complete this 26 
research. In total, 17 project meetings were held among the authors. Of these meetings, three 27 
were focus group discussions to develop a data extraction scheme in order to ensure that the 28 
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extracted data can address our research aim. The first focus group discussion involved three 1 
clinician authors to develop an initial list of 16 data variables for extraction. The second focus 2 
group involved six clinicians and a researcher in epidemiology to review and expand the list 3 
to 21 variables. The third focus group involved five clinicians to further scrutinise the data 4 
variables and one more variable- “number of AWS observations in the first 24 hours after 5 
presentation”- was added. A coding scheme, including the variables and their values, was 6 
developed by data extractor 1, then validated by six clinicians. For example, three possible 7 
values for the variable “thiamine administration” were parenteral thiamine, oral thiamine and 8 
no drug prescribed.  9 
The 21 data variables were grouped into seven categories:  10 
• Patient characteristics include eight variables: gender, age, length of stay, admission 11 
specialty, admission ward, triage code, presenting problem and postcode. 12 
• Identification of AUD includes three variables: screening tool used to assess the 13 
severity of AUD, whether AUD was identified at ED triage and who (job role) 14 
identified and documented AUD. 15 
• Documentation of alcohol use history includes one variable: who (job role) 16 
documented detailed history of AUD (e.g. duration, quantity, pattern of use, previous 17 
attempts to cut down alcohol intake and social impact). 18 
• Thiamine includes one variable: thiamine administration. Thiamine assists with 19 
nutritional deficiencies associated with AUD which, if untreated, may lead to 20 
Wernicke’s encephalopathy [23].  21 
• AWS assessment includes six variables: whether AWS was started prior to or after the 22 
medical officer's assessment, where was AWS first started, time to start AWS from 23 
presentation, number of AWS observations in the first 24 hours after presentation, 24 
maximum AWS score and documented alcohol withdrawal complications.  25 
• Benzodiazepine for alcohol withdrawal includes two variables: type of prescribed 26 
benzodiazepine and benzodiazepine regime for alcohol withdrawal. These two 27 
variables were used to examine the practice of prescribing benzodiazepine for 28 
withdrawal. 29 
• Referral to the DA-CL service includes one variable: whether the patient was referred 30 
to the DA-CL service following the clinical guideline. 31 
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2.3 Inter-rater agreement 1 
Data extraction was manually conducted by two medical officers with six years and 20 2 
months of hospital work experience, respectively. They have sufficient experience of using 3 
and extracting information from the eMR. They independently extracted the same 160 data 4 
points. A comparison of their records showed a Cohen’s Kappa score of 0.96; therefore, 5 
adequate agreement was achieved [32]. 6 
2.4 Data cleaning and analysis 7 
To ensure data accuracy, nine data validation rules were developed as the criteria to be used 8 
to detect inconsistencies, outliers and missing values in a large dataset [33]. Applying 9 
validation rules is a well-recognised method for checking data accuracy. For example, if no 10 
AWS was performed, then there should be no record of an AWS score. These rules were then 11 
applied to validate the data. Of the 3,360 data points manually extracted, 24 errors (0.7%) 12 
were identified in 19 patients’ records, and were corrected through mapping back to the 13 
original eMR. Descriptive statistical analysis was conducted using SPSS version 21 (IBM 14 
Corp, Armonk, NY, USA).  15 
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3 Results 1 
3.1 Patient characteristics 2 
The 210 presentations were made by 199 patients; 30.2% (60) female and 69.8% (139) male 3 
(see Table 1). Their age ranged from 14 to 90 years old (mean, 50.6, 95% confidence interval 4 
[CI], 48.11, 53.17). On average, a patient stayed in the hospital for 5.9 days (95% CI, 4.82, 5 
6.97).  6 
It is noteworthy that 91.4% (192) of the 210 presentations had an initial presenting problem 7 
not directly related to alcohol, e.g. abdominal pain, reflecting the difficulty of fully disclosing 8 
alcohol-related morbidity at the initial presentation. Among all the 210 presentations, 34.2% 9 
(72) were admitted by emergency medicine specialty in the short stay area. This is followed 10 
by general medicine (18.6%, 39), psychiatry (9%, 19), general surgery (8.1%, 17), 11 
gastroenterology (6.7%, 14) and others (23.3%, 49). 12 
3.2 Identification and management of patients with alcohol use disorder 13 
Overall, only 6.2% (13) of the 210 presentations were formally assessed by a Mental Health 14 
substance use form, as there was no formal alcohol screening tool in place. Figure 1 shows 15 
the percentage of patients with AUD in each of the six key management steps. Among all 16 
patient presentations, 77.1% (162) were identified with AUD in the initial contacts with 17 
medical staff such as ED medical officer, ED nurse or specialty medical officer. The 18 
percentage of patients in each key step decreased from 64.3% (135) with a documentation of 19 
alcohol use history, 49.5% (104) with thiamine prescribed, 48.1% (101) with AWS 20 
assessment to 41% (86) with a prescription of benzodiazepine for alcohol withdrawal.  21 
Of the 210 presentations, 38.6% (81) were referred to the DA-CL service and 61.4% (129) 22 
were not. Compared with the non-referred group, the referred one had higher proportion of 23 
female (32.1% [26/81] vs. 29.5% [38/129]), lower average age (46.5 vs. 52.7) and lower 24 
proportion of non-alcohol related presenting problems (85% [69/81] vs. 95.3% [123/129]).   25 
Of the 129 non-referred presentations, 83.7% (108/129) received no referral or advice. 26 
Although 4.7% (6/129) were advised to contact the Drug and Alcohol Service, no formal 27 
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referral was made. The rest 6.2% (8/129) of the patients declined referral or were abstinent, 1 
3.9% (5/129) were deceased and 1.6% (2/129) were discharged against medical advice. 2 
Of the 210 presentations, 8.6% (18) had presenting problems directly related to alcohol. 3 
These presentations had a higher completion rate of each of the six key steps than those with 4 
initial presenting problems not directly related to alcohol.  5 
3.3 Management of patients who developed moderate or severe alcohol withdrawal 6 
symptoms or complications 7 
The alcohol withdrawal scores showed that 27.6% (58) of all presentations developed 8 
moderate or severe withdrawal, and/or withdrawal complications (i.e. seizures, delirium and 9 
hallucinations). Table 2 shows that 15.5% of these 58 presentations did not have thiamine and 10 
20.7% received oral thiamine. In the first 24 hours since presentation, 24.1% of these did not 11 
receive any AWS assessment and 44.8% received one to four assessments. Regarding 12 
benzodiazepine regimes, only 1.7% were on loading dose, 34.5% were on symptom-triggered 13 
sedation and 31% did not have any prescription of benzodiazepine for withdrawal.  14 
3.4 Hospital re-presentation and re-admission 15 
As five patients were deceased in the index presentation, 194 patients were examined for 16 
their re-presentation, re-admission and attendance to the community-based Drug and Alcohol 17 
Service 17 months after discharge. Only 14% (27/194) of these patients attended the 18 
community-based Drug and Alcohol Service. 57% (111/194) re-presented to the ED, with 19 
31% (61/194) identified with AUD. 44% (86/194) were re-admitted (including direct ward 20 
admission) into the hospital, with 32% (63/194) identified with AUD. These patients 21 
occupied 1,939 hospital days and 63% (1,216/1,939) of these days were alcohol-related.  22 
 23 
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4 Discussion 1 
This study investigated the practice of identification and management of patients with AUD 2 
in an Australian teaching hospital. Medical records of 210 patient presentations with a 3 
primary or secondary diagnosis of AUD were audited. The results showed that more than 4 
90% of the presentations were not screened with a formal screening tool. Despite the well-5 
established evidence that early identification can inform optimal clinical management of 6 
alcohol-related morbidity [11], our study showed that more than a fifth of the presentations 7 
were not identified with AUD in the initial assessment by the triage nurse, ED medical officer, 8 
specialty medical officer or ward nurse. Approximately a third of these presentations did not 9 
have documentation of alcohol use history. More than half of them did not have thiamine, 10 
AWS assessment and benzodiazepine for alcohol withdrawal. More than 60% were not 11 
referred to the DA-CL service.  12 
Our audit found that alcohol screening was conducted for only 6% of the presentations, 13 
similar with what was found in a previous study that was also conducted in Australian 14 
hospitals [31]. It was also found that 23% of the presentations were not identified with AUD 15 
in the initial contact with medical staff, lower than the 30% found in a study conducted in an 16 
Australian trauma setting [15]. Identification of AUD and providing brief advice is a cost-17 
effective method to reduce alcohol-related morbidity in EDs [34]. Therefore, almost two 18 
thirds of 147 EDs surveyed in UK routinely screen patients’ alcohol consumption [35]. 19 
Because there is strong evidence of a positive impact of screening on the subsequent 20 
management of AUD [36], there is a need to formally include an alcohol screening tool in the 21 
routine assessment in the hospital.  22 
According to the local clinical guideline, AWS needs to be conducted second hourly in the 23 
first 12 hours and four to six hourly for the following 48 hours (Figure S1), which indicates 24 
that at least eight AWS observations should be recorded. Even this number might be an 25 
underestimate, our study found a lower number- only one to four AWS observations were 26 
recorded for most patients who exhibited moderate or severe withdrawal or developed 27 
withdrawal complications. 28 
Thiamine is commonly prescribed to treat patients with alcohol withdrawal. It assists with 29 
nutritional deficiencies associated with AUD, which, if left untreated, can lead to Wernicke’s 30 
encephalopathy [23]. However, for the 58 patients who suffered from moderate or severe 31 
13 
 
withdrawal or developed withdrawal complications, 16% were not prescribed with thiamine 1 
and 21% of them received oral thiamine even though parenteral thiamine is recommended as 2 
the optimal delivery method [27]. 3 
Our study reveals that there are three benzodiazepine regimes used for treating alcohol 4 
withdrawal: loading dose, fixed dose and symptom-triggered sedation. Loading dose regime 5 
uses high doses of longer-acting benzodiazepine at the commencement of treatment with no 6 
further tapering, to reduce withdrawal-related complications and symptomatology; whereas 7 
with fixed dose regime, benzodiazepine is administered at regular intervals, and tapered down 8 
over few days [17]. The symptom-triggered sedation regime can result in under-treatment by 9 
inexperienced staff who may not perform close monitoring of patient response. Because of 10 
this, our local guideline recommends using either the fixed or loading regimes (see Figure 11 
S2). Contradictory to this guideline, our study found that among the patients who developed 12 
moderate or severe alcohol withdrawal symptoms or complications, only 2% of them were on 13 
a loading dose regime. More than one third of them were sub-optimally prescribed the 14 
symptom-triggered benzodiazepine. Unexpectedly, more than 30% of the 210 patients did not 15 
receive any benzodiazepine. 16 
According to the local clinical guideline, all of the patients who were diagnosed with AUD 17 
should be referred to the hospital DA-CL service. However, in reality, more than 60% of 18 
these patients were not referred, missing the opportunity to optimise care and provide 19 
relevant education to these patients [37].  20 
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5 Limitation 1 
There is a potential under-reporting of AUD in the eMR because the study scope and 2 
resource limitation did not allow the assessment of the completeness of the eMR in the study 3 
hospital. However, the number of referrals to the DA-CL was validated by comparing the 4 
data extracted from the eMR and the referral list kept by the DA-CL. The comparison found 5 
that 22 referrals recorded by the DA-CL were not actually documented in the eMR. These 22 6 
referrals were then added to the audit results.  7 
The methodology of retrospective audit of eMR was also limited by the completeness and 8 
accuracy of the records at the data entry stage. The number of AWS recordings may be 9 
under-estimated if the action was taken but was not documented in the eMR by the clinicians. 10 
The results may also be affected by the spectrum of alcohol-related morbidity that was 11 
manifested in the patient population and the clinical judgment used by the two medical 12 
officers who extracted data to determine if a specified management step was implemented or 13 
not.  14 
15 
 
6 Conclusion 1 
This study identified gaps in the management of patients with AUD. It identified a need to 2 
routinely use an alcohol screening tool to screen patients at the initial presentation and to 3 
improve alcohol management of patients with AUD in the hospital. Future research is 4 
required to investigate why some patients with AUD were not referred to the DA-CL service 5 
and how to improve the management of these patients across the continuum of care.  6 
 7 
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8 Tables  1 
Table 1. Characteristics of patient presentations. 2 
Data variable Data value N (%) 
Gender 
(N=199) 
Female 60 (30.2) 
Male 139 (69.8) 
Age group 
(N=199) 
<20 10 (5) 
20-29 23 (11.6) 
30-39 21 (10.6) 
40-49 35 (17.6) 
50-59 42 (21.1) 
60-69 41 (20.6) 
70-79 18 (9) 
80-90 9 (4.5) 
Triage code 
(N=210) 
1. Immediately life threatening condition (has to be seen immediately) 8 (3.8) 
2. Imminently life threatening condition (has to be seen in 10 minutes) 38 (18.1) 
3. Potentially life threatening condition (has to be seen in 30 minutes) 100 (47.6) 
4. Potentially serious (has to be seen in 60 minutes) 37 (17.6) 
The patient was directly admitted to ward and was not seen by ED triage 27 (12.9) 
Presenting problem 
(N=210) 
Non-alcohol related  192 (91.4) 
Alcohol-related  18 (8.6) 
 3 
4 
22 
 
Table 2. Management of patients who exhibited moderate or severe withdrawal or 1 
developed withdrawal complications. 2 
Data variable Data value Number of 
presentations 
%  
(N=58) 
Thiamine 
administration 
Parenteral thiamine 37 63.8 
Oral thiamine 12 20.7 
No drug prescribed  9 15.5 
Where was AWS 
first started 
ED until discharge 25 43.1 
ED and continued on ward 1 1.7 
ED but discontinued on ward 5 8.6 
Ward (patients admitted through ED)  8 13.8 
Direct ward admission 5 8.6 
No AWS assessment was performed 14 24.1 
Time to commence 
AWS since triage or 
ward admission 
0 to 6 hours 22 37.9 
6 to 12 hours 12 20.7 
12 to 24 hours 5 8.6 
After 24 hours 5 8.6 
No AWS assessment was performed 14 24.1 
Number of AWS 
observations in the 
first 24 hours after 
presentation 
1 to 4 times 26 44.8 
5 to 7 times 9 15.5 
8 to 10 times 4 6.9 
None 19 32.8 
Type of prescribed 
benzodiazepine for 
alcohol withdrawal 
Diazepam 31 53.4 
Oxazepam 5 8.6 
Diazepam and oxazepam 4 6.9 
No drug prescribed  18 31 
Benzodiazepine 
regime for alcohol 
withdrawal  
Loading 1 1.7 
Fixed 15 25.9 
Symptom-triggered sedation 20 34.5 
Other 4 6.9 
No drug prescribed  18 31 
Referral to the DA-
CL service 
Yes 26 44.8 
No referral or advice 23 39.7 
No referral but patient was advised to contact the DA-CL 
service 
2 3.4 
No referral because of patient death 4 6.9 
No referral because the patient was discharged against 
medical advice 
1 1.7 
Patient declined referral or patient abstinent 2 3.4 
DA-CL: Drug and Alcohol Consultation Liaison 3 
 
Figure 1. Percentage of patients with alcohol use disorder in each of the six key management steps. 
All patient 
presentations 
with a diagnosis 
of alcohol use 
disorder
(N=210)
64.3% (135)
95% CI: 57.8-70.8%
77.1% (162)
95% CI: 71.5-82.8%
49.5% (104)
95% CI: 42.8-56.3%
48.1% (101)
95% CI: 41.3-54.9%
41% (86)
95% CI: 34.3-47.6%
38.6% (81)
95% CI: 32-45.2%
Presenting 
problem not
related to alcohol 
(N=192)
Presenting 
problem related 
to alcohol 
(N=18)
75% (144) 62% (119) 48.4% (93) 45.8% (88) 38.5% (74) 36.5% (70)
100% (18) 88.9% (16) 61.1% (11) 72.2% (13) 66.7% (12) 61.1% (11)
Step 1. 
Identification 
of AUD
Step 2. 
Documentation of 
alcohol use history
Step 3. 
Thiamine 
prescribed
Step 4. 
AWS assessment 
conducted
Step 5. 
Benzodiazepine 
prescribed
Step 6. 
Referral made to 
DA-CL service 
AUD: alcohol use disorder; AWS: Alcohol withdrawal scale; DA-CL: Drug and Alcohol Consultation Liaison
